Megestrol Acetate
The Active Substance of the Medication, Megestrol Acetate, is a Synthetic Progestagen for Oral Administration in the Form of a Suspension. It Causes Weight Gain due to Increased Appetite.
Cachexan is Indicated for the Treatment of Loss of Appetite (Anorexia) or Weight Loss due to Cancer or Acquired Immune Deficiency Syndrome (AIDS).
Before Starting to Use Cachexan, Consult Your Doctor or Pharmacist.
Cachexan Should be Used with Caution in Patients who have had Thrombophlebitis in the Past.
In Patients with Diabetes, an Increased Insulin Requirement may Occur.
During Treatment with Cachexan or After Stopping it, Clinical and Laboratory Signs of Mild Adrenal Suppression have been Reported. If the Medication is Stopped Suddenly, Patients Should be Closely Monitored for Symptoms such as Hypotension, Nausea, Vomiting, Dizziness, or Weakness.
Tell Your Doctor or Pharmacist about all Medications You are Currently Taking or have Recently Taken, as well as any Medications You Plan to Take.
No Confirmed Interactions between Megestrol Acetate and Other Medications have been Reported.
If You are Pregnant, Breastfeeding, or Think You may be Pregnant, or Plan to Become Pregnant, Consult Your Doctor or Pharmacist Before Using this Medication.
Cachexan Should not be Given to Pregnant or Breastfeeding Women.
The Effect of Cachexan on the Ability to Drive and Operate Machines is not Known.
This Medication Contains 29.34 mg of Alcohol (Ethanol - a Component of Orange Flavor) in each 20 ml of Suspension.
The Amount of Alcohol in 20 ml of this Medication is Equivalent to Less than 1 ml of Beer or 1 ml of Wine. The Small Amount of Alcohol in this Medication will not have a Noticeable Effect.
The Medication Contains Sucrose. If You have been Diagnosed with an Intolerance to some Sugars, Consult Your Doctor Before Taking the Medication.
This Medication Contains 2 mg of Sodium Benzoate in 1 ml of Suspension.
This Medication Contains Less than 1 mmol (23 mg) of Sodium in 1 ml of Suspension, which means the Medication is Considered "Sodium-Free".
Always Use this Medication Exactly as Your Doctor has Told You. If You are not Sure, Ask Your Doctor or Pharmacist.
Before Administration, the Suspension Should be Shaken Well.
Adults:400-800 mg (10 to 20 ml of Suspension), Orally.
Treatment with Cachexan Should be Continued for at Least Two Months.
There is Limited Data on the Use of Megestrol Acetate in Patients Aged 65 and Over, and it is not Possible to Determine whether it Works Differently in this Age Group Compared to Younger Patients. Based on Clinical Experience, no Differences in its Effects have been Observed in Elderly and Younger Patients. A Lower Dose Should be Chosen with Caution in the Elderly. Due to the Higher Frequency of Impaired Liver, Kidney, or Heart Function, as well as Concomitant Diseases and the Use of Other Medications, Treatment Usually Starts with a Dose from the Lower End of the Dose Range.
Megestrol Acetate is Mainly Excreted by the Kidneys. Therefore, the Risk of its Toxic Effects may be Higher in Patients with Impaired Renal Function. Since Impaired Renal Function is More Likely in the Elderly, Caution Should be Exercised when Determining the Dose. Monitoring of Renal Function may also be Useful.
Cachexan is not Recommended for Use in Children and Adolescents.
Consult a Doctor.
If Necessary, the Doctor will Provide Appropriate Supportive Treatment.
Do not Take a Double Dose to Make up for a Missed Dose.
If You have any Further Questions about Stopping this Medication, Consult Your Doctor or Pharmacist.
Like all Medications, Cachexan can Cause Side Effects, although not Everybody gets them.
Common Side Effects(Occurring in 1 to 10 Patients out of 100):
Side Effects with Unknown Frequency(Which cannot be Estimated from the Available Data):
If You Experience any Side Effects, including those not Listed in this Package Leaflet, Tell Your Doctor or Pharmacist.
Reporting Side Effects
If You Experience any Side Effects, including those not Listed in this Package Leaflet, Tell Your Doctor or Pharmacist, or Nurse. Side Effects can be Reported Directly to the Department of Drug Safety Monitoring of the Office for Registration of Medicinal Products, Medical Devices, and Biocidal Products:
Al. Jerozolimskie 181C
02-222 Warsaw
Phone: +48 22 49-21-301
Fax: +48 22 49-21-309
Website: https://smz.ezdrowie.gov.pl
Side Effects can also be Reported to the Marketing Authorization Holder.
By Reporting Side Effects, You can Help Provide More Information on the Safety of this Medication.
Keep this Medication out of the Sight and Reach of Children.
Do not Use this Medication after the Expiration Date Stated on the Carton and Bottle after "EXP". The Expiration Date refers to the Last Day of the Month.
Shelf Life after First Opening the Bottle - 6 Months.
Store in a Temperature below 25°C.
Medications should not be Disposed of via Wastewater or Household Waste. Ask Your Pharmacist how to Dispose of Medications no Longer Required. This will Help Protect the Environment.
White Suspension with an Orange Odor.
The Medication is Packaged in a 250 ml HDPE Plastic Bottle with a PP/HDPE Screw Cap, a PE Sealing Plug, an HDPE Guarantee Ring, and a Child-Resistant Closure, and a PP Measuring Cup, in a Cardboard Box.
Package Size: 1 Bottle Containing 240 ml of Suspension.
Polfarmex S.A.
ul. Józefów 9
99-300 Kutno
Phone: +48 24 357 44 44
Fax: +48 24 357 45 45
Need help understanding this medicine or your symptoms? Online doctors can answer your questions and offer guidance.